Unprotected sex among HIV-positive treatment-seeking opioid-dependent adults in China: A cross-sectional study

Sexually Transmitted Diseases

Volumn 39, Issue 12, 2012, Pages 930-937

  Zhang, Zhenghong ^a   Wu, Zunyou ^a   Poundstone, Katharine E ^a   Yin, Wenyuan ^a   Pang, Lin ^a   Rou, Keming ^a   Luo, Wei ^a   Cao, Xiaobin ^a   Wang, Changhe ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CHINA; CONFERENCE PAPER; FEMALE; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; OPIATE ADDICTION; SEXUAL BEHAVIOR; UNSAFE SEX;

ADULT; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; GOVERNMENT PROGRAMS; HEALTH BEHAVIOR; HEPATITIS C; HIV SEROPOSITIVITY; HUMANS; MALE; METHADONE; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; SEXUAL PARTNERS; SUBSTANCE ABUSE, INTRAVENOUS; UNSAFE SEX;

EID: 84870184397     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e318272c497     Document Type: Conference Paper

References (24)

1. Zhao M, Du J, Lu GH, et al. HIV sexual risk behaviors among injection drug users in Shanghai. Drug Alcohol Depend 2006; 82(suppl 1):S43YS47. Epub 2006/06/14.
2. Fu ZH, Gao MY, Chen L, et al. Study on herpes simplex virus 2 infection and risky sexual behavior among HIV-infected patients in a county of Yunnan province. Zhonghua Liu Xing Bing Xue Za Zhi 2009; 30:1139-1142. Epub 2010/03/03.
3. Metzger DS, Woody GE, O'Brien CP. Drug treatment as HIV prevention: A research update. J Acquir Immune Defic Syndr 2010; 55(suppl 1):S32YS36. Epub 2010/11/10.
4. Tross S, Campbell AN, Cohen LR, et al. Effectiveness of HIV/STD sexual risk reduction groups for women in substance abuse treatment programs: Results of NIDA Clinical Trials Network Trial. J Acquir Immune Defic Syndr 2008; 48:581-589. Epub 2008/07/23.
5. Calsyn DA, Crits-Christoph P, Hatch-Maillette MA, et al. Reducing sex under the influence of drugs or alcohol for patients in substance abuse treatment. Addiction 2010; 105:100-108. Epub 2010/01/19.
6. Calsyn DA, Hatch-Maillette M, Tross S, et al. Motivational and skills training HIV/sexually transmitted infection sexual risk reduction groups for men. J Subst Abuse Treat 2009; 37:138-150. Epub 2009/01/20.
7. Gordon CM, Forsyth AD, Stall R, et al. Prevention interventions with persons living with HIV/AIDS: State of the science and future directions. AIDS Educ Prev 2005; 17(1 suppl A):6-20. Epub 2005/04/22.
8. Mausbach BT, Semple SJ, Strathdee SA, et al. Efficacy of a behavioral intervention for increasing safer sex behaviors in HIV-positive MSM methamphetamine users: Results from the EDGE study. Drug Alcohol Depend 2007; 87:249-257. Epub 2006/12/22.
9. Purcell DW, Metsch LR, Latka M, et al. Interventions for seropositive injectorsVresearch and evaluation: An integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction. J Acquir Immune Defic Syndr 2004; 37(suppl 2):S110YS118. Epub 2004/09/24.
10. Yin W, Hao Y, Sun X, et al. Scaling up the national methadone maintenance treatment program in China: Achievements and challenges. Int J Epidemiol 2010; 39(suppl 2):ii29Yii37. Epub 2010/12/09.
11. Avants SK,Warburton LA, Hawkins KA, et al. Continuation of highrisk behavior by HIV-positive drug users. Treatment implications. J Subst Abuse Treat 2000; 19:15-22. Epub 2000/06/27.
12. Friedman SR, Jose B, Neaigus A, et al. Consistent condom use in relationships between seropositive injecting drug users and sex partners who do not inject drugs. AIDS 1994; 8:357-361. Epub 1994/03/01.
13. Kivela PS, Krol A, Partanen AL, et al. High prevalence of unprotected sex among Finnish HIV-positive and HIV-negative injecting drug users. Scand J Public Health 2009; 37:357-363. Epub 2009/04/18.
14. Kwiatkowski CF, Booth RE. HIV-seropositive drug users and unprotected sex. AIDS Behav 1998; 2:151-159.
15. Purcell DW, Mizuno Y, Metsch LR, et al. Unprotected sexual behavior among heterosexual HIV-positive injection drug using men: Associations by partner type and partner serostatus. J Urban Health 2006; 83:656-658. Epub 2006/06/01.
16. Marks G, Crepaz N, Senterfitt JW, et al. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: Implications for HIV prevention programs. J Acquir Immune Defic Syndr 2005; 39:446-453.
17. Gollub EL, Rey D, Obadia Y, et al. Gender differences in risk behaviors among HIV+ persons with an IDU history. The link between partner characteristics and women's higher drug-sex risks. The Manif 2000 Study Group. Sex Transm Dis 1998; 25:483-488. Epub 1998/11/04.
18. Somlai AM, Kelly JA, Benotsch E, et al. Characteristics and predictors of HIV risk behaviors among injection-drugYusing men and women in St. Petersburg, Russia. AIDS Educ Prev 2002; 14: 295-305. Epub 2002/09/06.
19. Kennedy CA, Skurnick J, Wan JY, et al. Psychological distress, drug and alcohol use as correlates of condom use in HIV-serodiscordant heterosexual couples. AIDS 1993; 7:1493-1499. Epub 1993/11/01.
20. Best D, Gossop M, Stewart D, et al. Continued heroin use during methadone treatment: Relationships between frequency of use and reasons reported for heroin use. Drug Alcohol Depend 1999; 53:191-195. Epub 1999/03/18.
21. Cao XB, Yin WY, Pang L, et al. Risk factors which were associated with heroin use during the methadone maintenance treatment among 1301 patients in 9 cities of China. Zhonghua Liu Xing Bing Xue Za Zhi 2010; 31:269-272. Epub 2010/06/01.
22. National Center for AIDS/STD Control and Prevention, Chinese Centers for Disease Control and Prevention. Annual report of statistics of national HIV/AIDS prevention, treatment, and care in China in 2009. Beijing, 2010.
23. Hao C, Hu W, Ruan YH, et al. Impact of community-based methadone maintenance treatment on high risk sexual behaviors among heroin addicts. Chin J AIDS STD 2006; 12:307-310.
24. Che YAS, Mcneil E, Chongsuvivatwong V, et al. Predictors of early dropout in methadone maintenance treatment program in Yunnan province, China. Drug Alcohol Rev 2010; 29:263-270.